SGMT
#2791
Sagimet Biosciences Inc. - Series A Common Stock
8.8 0 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.46%
Monthly Change
-19.71%
6 month change
+60.00%
Year Change
+17.33%
Previous Close
8.9 3
Open
8.8 5
Low
8.7 4
High
9.1 5
Financials
- Market Capitalization 547 M
- Employee 16
- Founded 2006
- CEO N/A
- Website www.sagimet.com
- Headquarter Delaware, United States
- FIGI BBG0020584Y9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.75
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2765 |  HELP Cybin Inc. - Common Stock | 11.03 USD | -6.53% | -2.82% | -14.16% | +22.97% | 569.50 M USD | ||
| 2772 |  DBVT DBV Technologies S.A. - American Depositary Shares | 9.55 USD | -2.55% | -10.24% | -21.72% | -37.50% | 565.48 M USD | ||
| 2812 |  PBYI Puma Biotechnology Inc - Common Stock | 10.29 USD | 0.00% | +5.00% | +13.08% | +96.00% | 531.17 M USD | ||
| 2817 |  CTMX CytomX Therapeutics, Inc. - Common Stock | 2.42 USD | -5.84% | -6.56% | -26.67% | -27.76% | 527.32 M USD |
Frequently asked questions about Sagimet Biosciences Inc. Series A Common Stock
What is the Sagimet Biosciences Inc. Series A Common Stock stock price today?
The current price of Sagimet Biosciences Inc. Series A Common Stock (SGMT) is 8.80. Over the past 24 hours, the stock has changed by -1.46%. Follow the SGMT chart for real-time price dynamics.
What is the stock ticker of Sagimet Biosciences Inc. Series A Common Stock?
Sagimet Biosciences Inc. Series A Common Stock trades under the ticker SGMT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Sagimet Biosciences Inc. Series A Common Stock stock going up?
SGMT has changed by -2.11% over the last week, -19.71% over the last month, and +17.33% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Sagimet Biosciences Inc. Series A Common Stock?
Sagimet Biosciences Inc. Series A Common Stock currently has a market capitalization of 547 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Sagimet Biosciences Inc. Series A Common Stock earnings last quarter?
Last quarter, Sagimet Biosciences Inc. Series A Common Stock reported earnings of -0.26 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Sagimet Biosciences Inc. Series A Common Stock net income for the last quarter?
Sagimet Biosciences Inc. Series A Common Stock reported net income of -13.95 M for the last quarter. The previous quarter showed -10.65 M, which means net income changed by -31.01%.
How many employees does Sagimet Biosciences Inc. Series A Common Stock have?
As of the latest available data, Sagimet Biosciences Inc. Series A Common Stock has 16 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Sagimet Biosciences Inc. Series A Common Stock stock?
You can buy Sagimet Biosciences Inc. Series A Common Stock (SGMT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Sagimet Biosciences Inc. Series A Common Stock stock?
Investing in Sagimet Biosciences Inc. Series A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SGMT chart and related analysis on metatrader.com as part of your research.